Trupanion, Inc. (TRUP) AI Stock Analysis

Trupanion, Inc. specializes in offering medical insurance plans for cats and dogs through a subscription-based model across the United States, Canada, Puerto Rico, and Australia. Founded in 2000 and headquartered in Seattle, Washington, the company operates primarily through two segments: Subscription Business and Other Business. Its services cater to pet owners seeking comprehensive coverage for veterinary expenses, providing financial protection against unexpected healthcare costs for their pets. Trupanion focuses exclusively on pet insurance, delivering subscription plans covering a wide range of medical treatments and procedures while fostering relationships with veterinarians and pet owners.

Trupanion generated revenue of $1.44B in FY2025, up 11.9% from $1.29B in FY2024 and expanding at a 5-year revenue CAGR of 23.4% from FY2020. Gross margin rose to 28.5% in FY2025 from 13.9% in FY2024, while operating margin turned positive at 1.5% compared to -0.7% in FY2024 and -5.0% in FY2021. Net income reached $19.4M in FY2025, yielding an EPS of $1.31 after losses of -$9.6M in FY2024 and -$44.7M in FY2023. Over the trailing twelve months, revenue totaled $1.52B with an operating margin of 1.6%. In the latest quarter ended June 30, 2026, quarterly revenue grew 11.1% year-over-year, while quarterly earnings declined 28.9%.

As of June 30, 2026, Trupanion held $398.5M in cash and short-term investments against total debt of $106.9M, resulting in net cash of $291.6M. Total assets stood at $930.8M, supported by shareholders' equity of $409.7M. The company maintains a current ratio of 1.77 and a debt-to-equity ratio of 0.26. In FY2025, operating cash flow was $89.5M and free cash flow reached $75.4M. Capital expenditures totaled $14.1M, and share buybacks were $3.7M, while share count increased 8.4% over 5 years.

At its last close of $28.12 on October 16, 2026, Trupanion has a market cap of $1.23B and an enterprise value of $710.9M. The stock trades at a trailing P/E of 53.1x, above the 12.1x median of its US-listed Financial Services peers. Its price-to-sales ratio of 0.8x sits below the peer median of 3.2x, while its EV/EBITDA is 13.6x compared to the peer median of 11.7x. Over the past year, TRUP returned -33.8% compared to a 16.8% gain for the S&P 500 (SPY). Over five years, the stock returned -69.2% versus an 83.0% gain for SPY.

Wall Street coverage consists of 2 Strong Buy and 4 Hold ratings, with no Buy, Sell, or Strong Sell recommendations. The mean price target is $33.25, representing an 18.2% premium over the last close of $28.12. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $1.59B and EPS of $4.04, reflecting estimated EPS growth of 46.6%. The company has beaten EPS estimates in 1 of the last 4 quarters. The next earnings date is November 5, 2026.

This page is an AI-written research summary of Trupanion, Inc. (TRUP). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: TRUP income statement, TRUP balance sheet, TRUP key metrics, TRUP analyst forecast, TRUP chart. See the TRUP stock overview for the latest quote and news.